CORRECTED-Biotech companies Alnylam, Dicerna settle trade secrets case

BOSTON, April 20 (Reuters) - Dicerna Pharmaceuticals Inc on Friday said it will pay $15 million plus stock to Alnylam Pharmaceuticals Inc to resolve a lawsuit claiming it stole trade secrets about gene-silencing technology used to develop drug treatments.